tenk.fyi

IMMUCELL CORP /DE/

ICCCNasdaq· In Vitro & In Vivo Diagnostic Substances

Price History

Revenue

$27.6M

4.3% YoY

Net Income

-$1.0M

51.8% YoY

EPS

$-0.12

53.8% YoY

Cash

$3.8M

1.3% YoY

FY 2025 · As of 2025-12-31